Technical analysis from Reata Pharmaceuticals (RETA, NASDAQ:RETA) on the NASDAQ Stock Exchange (NASDAQ). Download the latest price data & trading signals

Reata Pharmaceuticals
+ Share

Reata Pharmaceuticals has broken the first DeMark resistance point ($33.96) [Bullish]
Demarks Pivot Points /
Reata Pharmaceuticals has broken the first DeMark resistance point ($33.96) [Bullish]

Reata Pharmaceuticals has broken the first DeMark support point ($33.96) [Bearish]. Look for a short limit order entry near this point. Exit price for RETA should be set @$31.9900 & short position stoploss for Reata Pharmaceuticals should be set at $34.77

Reata Pharmaceuticals: Current trading activity signals DVI accumulation is present
Daily Volume Index /
Reata Pharmaceuticals: Current trading activity signals DVI accumulation is present

[BULLISH]: Reata Pharmaceuticals current accumulation has given strength to the share price and the continuation of bullish trading conditions. Currently, the DVI is 2506.

Closing Price /
Close for RETA has not surpassed the close of the previous trading session

RETA: CLOSE Current Signal -> (1) 25 May: BEARISH (2) 24 May: BULLISH (3) 23 May: BULLISH

Commodity Channel Index /
Potential continuation of a trend reversal (Bearish) for Reata Pharmaceuticals

[BEARISH]: Reata Pharmaceuticals current trading has maintained the Commodity Channel Index to overbought status and signalled the continuation of the bearish trading conditions. Currently, the CCI is 126. The bearish signal has been active for 0 day. During the quarter, the highest CCI value was 230.

Bill Williams Market Facilitation /
Reata Pharmaceuticals: Bill Williams Profanity [Green Day]

Reata Pharmaceuticals Currently is a confirmed Green Day. Both MFI & volume are down for RETA. Trend continuation likely for RETA from increased trading activity.

Elder Ray Index /
[Bullish]: Recent trading has driven price above the consensus of value for RETA

[BULLISH]: Reata Pharmaceuticals Elder Ray Index is signalling a Bullish movementERI is 4.148 indicating bull power. Prices are being driven above the consensus of value for RETA during the last trading session [Buying Pressure]

Top companies for
NASDAQ Stock Exchange
Advertisment
Ulcer Index /
Ulcer index has reduced in stress level & low drawdown is expected for Reata Pharmaceuticals

[BEARISH]: Reata Pharmaceuticals UIX index implies that the downside risk of the current trading price is low. Currently, the UIX is 1.436.

MACD /
RETA: Moving Average Convergence Divergence [Bullish]

RETA: MACD Current Signal -> (1) 25 May: BULLISH (2) 24 May: BULLISH (3) 23 May: BULLISH

Advertisment
Simple Moving Average(5) signal continues for Reata Pharmaceuticals indicating upward price movement is likely
Simple Moving Average /
Simple Moving Average(5) signal continues for Reata Pharmaceuticals indicating upward price movement is likely

[BULLISH]: Reata Pharmaceuticals currently has a confirmed uptrend. Recent trading has caused the SMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SMA5 is -1.1%.

Reata Pharmaceuticals: Look for a long limit order entry @$35.31
Pivot Points /
Reata Pharmaceuticals: Look for a long limit order entry @$35.31

Reata Pharmaceuticals has broken the first resistance point ($35.31) [Bullish]. Look for a long limit order entry near this point. Exit price for RETA should be set @$37.01 & Stoploss for Reata Pharmaceuticals should be set between $31.45 & $29.75

Aroon Oscillator /
RETA: Aroon oscillator has confirmed an strong uptrend @92

[BULLISH]: Reata Pharmaceuticals has a current ARU(25) of 100 and a current ARD(25) of 8

Price Range /
Range for RETA has surpassed the range of the previous trading session

RETA: Price Range Current Signal -> (1) 25 May: BULLISH (2) 24 May: BEARISH (3) 23 May: BULLISH

Stochastic Oscillator /
Stochastic Overbought signal is still current for Reata Pharmaceuticals [Bearish]

[BEARISH]: Reata Pharmaceuticals is currently Overbought highlighting the potential for a short term trend reversal in the downward direction.

Price is currently above the displaced moving average for RETA [Bullish]
Detrended Price Oscillator /
Price is currently above the displaced moving average for RETA [Bullish]

RETA: DPO Current Signal -> (1) 25 May: BULLISH (2) 24 May: BULLISH (3) 23 May: BULLISH

Reata Pharmaceuticals is still Overbought with the Relative Strength Index @79.2
Relative Strength Index /
Reata Pharmaceuticals is still Overbought with the Relative Strength Index @79.2

[BEARISH]: Reata Pharmaceuticals is currently Overbought highlighting the potential for a short term trend reversal in the downward direction. RSI is currently overbought @79.2

Close Tod Vs Range Tod /
The daily battle of control for Reata Pharmaceuticals was won by the sellers

[BEARISH]: Reata Pharmaceuticals sellers in control. This is the first day of seller commitment for Reata Pharmaceuticals adding strength to an downtrend in the first timeframe & highlights the lack of commitment of buyers to carry positions overnight Over the last 12 months there has been 92 trading days with the closing price in the lower part of the range giving a confirmation ratio of 35%. Over the last month there has been 5 trading days with the closing price in the lower range giving a confirmation ratio of 26.3%. Currently this quarter, closing price has spent 11 days in the lower price range compared to 19 days in the upper range giving a ratio of 0.6x.

Elders Force Index /
[Buying Pressure]: EFI (155225) confirms bullish conditions for Reata Pharmaceuticals

[BULLISH]: Reata Pharmaceuticals current price has highlighted recent buying pressure. Currently, the Elders Force Index is 155225.

Open/close reversal confirmed for Reata Pharmaceuticals signalling the buyers have lost control
Open Tod Vs Close Tod /
Open/close reversal confirmed for Reata Pharmaceuticals signalling the buyers have lost control

[BEARISH]: Reata Pharmaceuticals opened in the lower part of daily range at 30.6% & closed in the lower part of the trading range at 16.5%. This suggests the buyers have lost control. Over the last 12 months there has been 16 trading days with the opening price in the lower shadow & the closing the price in the lower shadow giving a confirmation ratio of 6.1%. Over the last month there has been 1 trading days with the opening price in the lower price range & the closing the price in the lower price range giving a confirmation ratio of 5.3%.

[Uptrend]: Recent trading for RETA indicates ST trend is likely to continue
Sine Weighted Moving Average /
[Uptrend]: Recent trading for RETA indicates ST trend is likely to continue

[BULLISH]: Reata Pharmaceuticals currently has a confirmed uptrend. Recent trading has caused the SWMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on SWMA5 is -1.1%.

Limit order for a long position has been identified for Reata Pharmaceuticals [Bullish]
Woodie Pivot Point /
Limit order for a long position has been identified for Reata Pharmaceuticals [Bullish]

Reata Pharmaceuticals has broken the first Woodie support point ($32.22) [Bearish]. Look for a short limit order entry near this point. Exit price for RETA should be set @$31.295 & short position stoploss for Reata Pharmaceuticals should be set at $36.855

Close Tod Vs Close Yest /
Sellers are now keener than buyers for Reata Pharmaceuticals & are driving the price down.

RETA: Recent performance signals ->(1) 25 May: NEUTRAL (2) 24 May: BULLISH (3) 23 May: BULLISH

Average True Range /
Recent trading indicates ATR upward trend direction likely for RETA [Uptrend]

RETA: Average True Range Recent Trading -> (1) 25 May: 1.761 (2) 24 May: 1.683 (3) 23 May: 1.742

Low Price /
Reata Pharmaceuticals: Daily low price is $33.15 [Lower low]

[BULLISH]: Reata Pharmaceuticals current downtrend in the first timeframe. Currently, the Low is $33.15 (-0.3 %).

MACD Volume /
Volume MACD for Reata Pharmaceuticals continues to gain momentum @8856

[BULLISH]: Reata Pharmaceuticals currently has positive Volume MACD of 8856. This means the signal line is greater than the Volume MACD line signalling a bullish movement.

Price continues to trade above the Triangular Moving Average(5) for RETA
Triangular Moving Average /
Price continues to trade above the Triangular Moving Average(5) for RETA

[BULLISH]: Reata Pharmaceuticals currently has a confirmed uptrend. Recent trading has caused the TMA 5 day average to exceed the closing price confirming the short term trend following indicator. Currently, the return on TMA5 is -1.1%.

Reata Pharmaceuticals: 3rd timeframe trend Uptrend remains intact
Long Trend /
Reata Pharmaceuticals: 3rd timeframe trend Uptrend remains intact

[BULLISH]: Reata Pharmaceuticals is in an uptrend in the medium term timeframe. The current rally number is 15 & the highest rally count for the LTM is 15. The highest rally for the month is 19

Volume /
Reata Pharmaceuticals: Daily volume is 292334 [Higher Volume]

[BULLISH]: Reata Pharmaceuticals current volume uptrend in the first timeframe. Volume for RETA is 292334 (23.9).

See More   See more results
Advertisment
Advertisment
back to top